# Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D

> **NCT05252728** · — · COMPLETED · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 372 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus Maturity Onset

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05252728
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05252728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05252728, "Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05252728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*